The global blood
coagulation tubes market is projected to grow at a substantial rate over
the forecast period. Increase in health awareness among the global population
has led to increase in blood diagnostic tests, especially coagulation tests.
Increasing prevalence of low platelet count or thrombocytopenia, increased
prevalence of liver diseases, as well as growth in number of surgeries are factor
that argue well for growth of the market.
Blood coagulation or clotting is
the mechanism by which blood changes its form from liquid to a highly
viscousgel-like form known as clot. The process is called hemostasis, which
prevents blood loss from damaged blood vessels. The process of coagulation
consists of activation, bonding, and accumulation of platelets accompanied by
deposition and development of fibrin. Thrombosis and hemorrhage are some of the
major coagulation disorders.
Coagulation tests primarily
measure the body plasma’s ability to clot as well as time taken for the same.
Coagulation testing helps doctors assess risk of extreme bleeding or developing
thrombosis inside blood vessels. Coagulation tests are conducted in a similar
manner as most blood tests. Side effects are minimal in these tests.
Coagulation disorders can cause hazardous amounts of blood loss or excessive
clotting. If the doctor suspects a coagulation disorder, more coagulation tests
may be carried out to confirm the same. These tests are useful for measuring
several proteins and their functions. Conditions that can cause clotting
disorders include liver disease, thrombophilia (excessive clotting), and
hemophilia (inability to clot normally). Moreover, coagulation tests are
beneficial for people who take medicines that affects their blood coagulation
ability. Coagulation tests are also carried out before certain surgeries
depending on the history and condition of the patient.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/139
Blood coagulation tubes primarily
contain a solution of tri-sodium citrate. The citrate concentrations are
available in two varieties namely0.129 mol/l (3.8%) and0.109 mol/l (3.2%). The
mixing ratio is usually one portion citrate to nine portions blood. These tubes
also contain adenosine, theophilline, and dipyridamole. One of the most
important aspects to be kept in mind is that these tubes must be completely
filled, as short draw tubes might not serve the purpose. The side effects of a
coagulation test are usually negligible. Patient might experience minor
soreness or bruising at the site. The other risks are lightheadedness, pain,
and infection(s).
Increased prevalence of
thrombosis and liver diseases a major driver for growth of global blood
coagulation tubes market
According to American Liver
Foundation, in 2013, around 30 million people in the U.S.—a whopping 10% of the
population—suffered from some form of liver disease. Liver disease is also
considered to be the ‘fifth big killer’ in England and Wales, in 2013, as per
the WHO-HFA database. Blood coagulation tubes are widely used for diagnosing
thrombosis. According to Center for Disease Control and Prevention (CDC), as
many as 900,000 people in the U.S. suffer from thrombosis each year. Fibrinogen
activity is tested to evaluate bleeding disorders. They are used to diagnose
diseases such as disseminated intravascular coagulation. As per Department of
Medicine, University of Alabama at Birmingham, in South Asia, especially in
India, the fibrinogen levels are usually high, due to high occurrences of
coronary heart diseases and higher levels of wound-induced glycoprotein
IIb/IIIa that acts as a receptor for fibrinogen. This in turn will result in
increased blood coagulation tests in this region. This creates a highly
conducive environment for growth of the blood coagulation tubes industry in the
region. A report by Journal of Thrombosis and Hemostatis, emphasizes upon the
need for controlled and randomized assessments with clinical result measurement
to establish that thromboprophylaxis (prevention of thromboembolic disease or
obstruction of blood vessels by blood clot) is essential in joint surgery in
Asia.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/blood-coagulation-tubes-market-139
Since blood coagulation tests are
usually suggested before and after a surgery, growth in number of surgeries is
expected to provide major growth traction to the blood coagulation tubes
market. As per independent estimates, around 232 million surgeries are
performed worldwide each year. Europe and North America are highest revenue
contributors to the global blood clotting tubes market. This is mainly
attributed to robust healthcare infrastructure and easy access to advanced
healthcare facilities in these regions. However, Asia Pacific is expected to
emerge as a high growth region in the global blood coagulation market, due to
increase in adoption of blood coagulation tests and high prevalence of heart
attack and stroke, along with rising incidence of thrombosis and chronic liver
diseases in the region.
Some of the major competitors
operating in the blood coagulation tubes industry are Medical Expo, Ajosha
BioTeklik Pvt. Ltd., CML Biotech Pvt. Ltd., New MicroMed International Pvt.
Ltd., Greiner BioOne, Gosselin, FL Medical, and Advacare Pharma.
Key Developments:
Product launches and continuous
innovations by key market players are expected to facilitate growth of the
blood coagulation tubes market. For instance, in August 2019, medical device
company Q-Sera Pty Ltd. announced that their Q-Sera technology, a blood
clotting technology to be used in blood collection tubes, has been granted
patent in the U.S. by the United States Patent & Trademark Office.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/139
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200 Seattle,
WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment